Cargando…

Bradykinin-induced angioedema in the emergency department

BACKGROUND: Acute airway angioedema commonly occurs through two distinct mechanisms: histamine- and bradykinin-dependent. Although they respond to distinct treatments, these two potentially life-threatening states present similarly. Poor recognition of the bradykinin-dependent pathway leads to treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hébert, Jacques, Boursiquot, Jean-Nicolas, Chapdelaine, Hugo, Laramée, Benoit, Desjardins, Marylin, Gagnon, Rémi, Payette, Nancy, Lepeshkina, Oleksandra, Vincent, Matthieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966254/ https://www.ncbi.nlm.nih.gov/pubmed/35350995 http://dx.doi.org/10.1186/s12245-022-00408-6

Ejemplares similares

In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020)

A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
por: Defendi, Federica, et al.
Publicado: (2013)

Pathophysiology of bradykinin and histamine mediated angioedema
por: Lima, Hermenio, et al.
Publicado: (2023)

Bradykinin Metabolism and Drug-Induced Angioedema
por: Smolinska, Sylwia, et al.
Publicado: (2023)

Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors
por: Marceau, François, et al.
Publicado: (2019)

Correction: Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
Publicado: (2014)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
por: Riedl, Marc
Publicado: (2010)

Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2019)

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
por: Debreczeni, Márta L., et al.
Publicado: (2021)

Picomolar Sensitivity Analysis of Multiple Bradykinin-Related Peptides in the Blood Plasma of Patients With Hereditary Angioedema in Remission: A Pilot Study
por: Marceau, François, et al.
Publicado: (2022)

Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency
por: Charest-Morin, Xavier, et al.
Publicado: (2018)

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
por: Aygören-Pürsün, Emel, et al.
Publicado: (2018)

Corrigendum: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2020)

Commentary: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Colobran, Roger
Publicado: (2020)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges
por: Mormile, Ilaria, et al.
Publicado: (2023)

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Dyga, Wojciech, et al.
Publicado: (2022)

A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
por: Nunes, Lisete Rolo, et al.
Publicado: (2023)

Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema
por: Maurer, Marcus, et al.
Publicado: (2021)

Evaluation and Management of Angioedema in the Emergency Department
por: Long, Brit Jeffrey, et al.
Publicado: (2019)

The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2019)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
por: Campos, Regis Albuquerque, et al.
Publicado: (2014)

Correction to: The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2020)

Angioedema in the emergency department: clinical presentation and outcomes
por: Felder, Sarah L, et al.
Publicado: (2014)

Hereditary angioedema: how to approach it at the emergency department?
por: Serpa, Faradiba Sarquis, et al.
Publicado: (2021)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema()
por: Can, Pelin Kuteyla, et al.
Publicado: (2021)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study
por: Schulkes, Karlijn J G, et al.
Publicado: (2015)

Clinical Features and Outcomes Associated with Angioedema in the Emergency Department
por: Sandefur, Benjamin J., et al.
Publicado: (2019)

Management of hereditary angioedema: 2010 Canadian approach
por: Bowen, Tom, et al.
Publicado: (2010)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

Gastrointestinal Manifestations of Hereditary Angioedema Diagnosed by Ultrasound in the Emergency Department
por: Riguzzi, Christine, et al.
Publicado: (2014)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014)

Plasminflammation—An Emerging Pathway to Bradykinin Production
por: Maas, Coen
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r3g7u2nfoi9nqp4q1kv0nub1kj